Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 1
Need and value of targeted immunosuppressive therapy in giant cell arteritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: Need and value of targeted immunosuppressive therapy in giant cell arteritis - March 01, 2022
PDF
Vasculitis
Review
Need and value of targeted immunosuppressive therapy in giant cell arteritis
Online download statistics by month:
Online download statistics by month: February 2022 to December 2022
Abstract
Full
Pdf
Feb 2022
325
332
154
Mar 2022
142
138
73
Apr 2022
67
63
26
May 2022
110
108
40
Jun 2022
70
66
22
Jul 2022
302
298
19
Aug 2022
83
85
23
Sep 2022
106
107
24
Oct 2022
101
101
21
Nov 2022
59
54
13
Dec 2022
63
61
8
Total
1428
1413
423
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF